IL-8 enhancement of amyloid-beta (Aβ1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia

被引:78
作者
Franciosi, S
Choi, HB
Kim, SU
McLarnon, JG
机构
[1] Univ British Columbia, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Fac Med, Div Neurol, Dept Med, Vancouver, BC V6T 2B5, Canada
[3] Ajou Univ, Brain Dis Res Ctr, Suwon, South Korea
关键词
human microglia; amyloid beta; interleukin-8; brain inflammation; cytokine; cyclooxygenase-2;
D O I
10.1016/j.jneuroim.2004.10.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effects of the chemokine IL-8 on amyloid beta peptide (Abeta(1-42))-induced responses in cultured human microglia were investigated using RT-PCR, ELISA and immunocytochemistry. Abeta(1-42) (5 muM) applied for 8 h induced the expression and increased the production of the pro-inflammatory cytokines IL-6, IL-1beta, TNF-alpha, the inducible enzyme COX-2 and chemokine IL-8. Microglial treatment with IL-8 added (at 100 ng/mL) with Abeta(1-42) led to enhancement in both expression and production of all of these pro-inflammatory factors compared with peptide alone. Stimulation with IL-8 itself was effective in increasing microglial expression of pro-inflammatory cytokines, IL-8 and COX-2, however, had no effect on protein levels of all these factors. The expression of the anti-inflammatory cytokines IL-10 and TGFbeta(1) remained unchanged from basal levels with stimulation using either Abeta(1-42), IL-8 or the peptide together with IL-8. The actions of IL-8 to potentiate Abeta(l-42)-induced inflammatory mediators may have particular relevance to Alzheimer disease brain which exhibits elevated levels of the chemokine. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 43 条
[1]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]  
BADOLATO R, 1995, J IMMUNOL, V155, P4004
[3]   INFLAMMATORY CYTOKINES WITHIN THE CENTRAL-NERVOUS-SYSTEM - SOURCES, FUNCTION, AND MECHANISM OF ACTION [J].
BENVENISTE, EN .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01) :C1-C16
[4]   Differential activation of subtype purinergic receptors modulates Ca2+ mobilization and COX-2 in human microglia [J].
Choi, HB ;
Hong, SH ;
Ryu, JK ;
Kim, SU ;
McLarnon, JG .
GLIA, 2003, 43 (02) :95-103
[5]   Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-α and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195 [J].
Choi, HB ;
Khoo, C ;
Ryu, JK ;
van Breemen, E ;
Kim, SU ;
McLarnon, JG .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (03) :546-555
[6]  
Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO
[7]  
2-J
[8]   THE AMYLOID BETA-PROTEIN OF ALZHEIMERS-DISEASE IS CHEMOTACTIC FOR MONONUCLEAR PHAGOCYTES [J].
DAVIS, JB ;
MCMURRAY, HF ;
SCHUBERT, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (02) :1096-1100
[9]  
Ehrlich LC, 1998, J IMMUNOL, V160, P1944
[10]  
Frautschy SA, 1998, AM J PATHOL, V152, P307